Clinical Trials
AstraZeneca establishes Scientific Review Board to support clinical trial data transparency commitment
AstraZeneca today announced the creation of a Scientific Review Board that will act independently to assess requests from external researchers which include patient level...
Clinical Trials
UCB clinical trials policy
UCB is committed to providing the opportunity to patients to make informed decisions about participating in clinical trials. UCB is committed...
Clinical Trials
clinical trials are critical for determining the safety and efficacy of new medicines and are integral to Roche’s strategy of developing innovative medicines and...
Roche is committed to sharing data from clinical trials and has registered and posted summary reports for trials involving patients on clinicaltrials.gov and on...
Clinical Trials
Disclosure Policy of the Astellas Group for Information on Conduct and Results of Clinical Trials.
The Astellas Group (*1) (hereinafter collectively “Astellas”) recognises that making clinical trial information and results more widely available to researchers, healthcare professionals, patients, and...
News
New study investigating the effect of low-molecular-weight heparins on the treatment of blood clots in cancer patients
The largest completed study to date on treatments to reduce recurrence of blood clots in cancer patients, sponsored by LEO Pharma, has now been...
News
LEO Pharma invests in mobile application company
LEO Pharma A/S, a global healthcare company dedicated to helping people achieve healthy skin, invests in privately owned SkinVision B. V., a derma focused...
News
New governance at LEO Pharma and LEO Foundation
Poul Rasmussen will retire at the end of this year as Chairman of LEO Pharma and Chairman of the LEO Foundation. Lars Olsen, Executive...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read